Ceragon Networks Ltd (CRNT)
Official siteTECHNOLOGY • COMMUNICATION EQUIPMENT • NASDAQ
Market Cap: $218.16M
Last updated: Nov 17, 2026 at 11:04 AM ET
Ceragon Networks Ltd (CRNT) Stock Forecast
Analysts expect Ceragon Networks (CRNT) to earn $0.12 per share in the fiscal year ending Dec 31, 2026, on revenue of $369.65M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 5 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 16.7% |
| Buy | 5 | 83.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 41.7% and revenue estimates rise 6.2%.
- Fiscal year ending Dec 31, 2026
- $0.12
- EPS consensus, revenue $369.65M
- Fiscal year ending Dec 31, 2027
- $0.17
- EPS consensus, revenue $392.55M
- Next report
- Feb 15, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.12 | $0.11 to $0.12 | 5 | $369.65M | $366.44M to $371.59M | 6 |
| Dec 31, 2027 | $0.17 | $0.15 to $0.20 | 5 | $392.55M | $382.00M to $396.60M | 6 |
Quarterly Estimates
The EPS consensus is $0.03 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.03 | $0.02 to $0.05 | 8 | $97.03M | $90.16M to $102.01M | 8 |
| Mar 31, 2027 | $0.03 | $0.01 to $0.04 | 4 | $93.14M | $91.00M to $95.20M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 7 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 5 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 9.1% from $0.11.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.12 | $0.10 | $0.10 | $0.10 | $0.11 | +7.9% |
| Fiscal year ending Dec 31, 2027 | $0.17 | $0.18 | $0.18 | $0.18 | $0.18 | -2.2% |
| Quarter ending Mar 31, 2027 | $0.03 | $0.03 | $0.03 | $0.03 | $0.04 | -31.3% |
Frequently Asked Questions About CRNT
What is the CRNT stock forecast?
Consensus analyst estimates put Ceragon Networks's EPS at $0.12 for the fiscal year ending Dec 31, 2026, on revenue of $369.65M. The consensus rating from 6 analysts is Buy.
How do analysts rate CRNT stock?
Of 6 analysts covering Ceragon Networks, 1 rates it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CRNT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.12, with estimates from $0.11 to $0.12 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.17, with estimates from $0.15 to $0.20 from 5 analysts.
What revenue do analysts expect from Ceragon Networks next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $369.65M, with estimates from $366.44M to $371.59M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $392.55M, with estimates from $382.00M to $396.60M.
How many analysts cover CRNT?
6 analysts rate Ceragon Networks stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CRNT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors